526 Results for "

PD 1

" in MedChemExpress (MCE) Product Catalog:
Products (526)

526 Results for "PD 1" in MCE Product Catalog:

  • Targets Recommended:
  • Recombinant Proteins Recommended:
35
35 Publications Verification
製品番号: HY-P9902A
別名: MK-3475 (anti-PD-1); Lambrolizumab (anti-PD-1)

Target:  

PD-1/PD-L1

研究分野:  

Cancer

Pembrolizumab (anti-PD-1) is a humanized IgG4 antibody and PD-1 inhibitor. Pembrolizumab produces PD-1 blockade, preventing PD-L1 and PD-L2 from connecting to PD-1. This avoids the uncontrolled regulation of T cells on cells that normally express PD-1 .
loading...
    loading...
35
35 Publications Verification
製品番号: HY-P9902
CAS 番号: 1374853-91-4
別名: MK-3475; Lambrolizumab

Target:  

PD-1/PD-L1

研究分野:  

Cancer

Pembrolizumab (MK-3475) is a humanized IgG4 antibody inhibiting the programmed cell death 1 (PD-1) receptor, used in cancer immunotherapy.
loading...
    loading...
35
35 Publications Verification
製品番号: HY-136927
CAS 番号: 129425-81-6
純度:  99.81%
Target:  

STING

研究分野:  

Inflammation/Immunology Cancer

MSA-2, a potent and orally available non-nucleotide STING agonist, is bound to STING as a noncovalent dimer with nanomolar affinity. MSA-2 shows EC50s of 8.3 and 24 μM for human STING isoforms WT and HAQ, respectively. MSA-2 stimulates interferon-β secretion in tumors, induces tumor regression with durable antitumor immunity, and synergizes with anti-PD-1 in syngeneic mouse tumor models .
loading...
    loading...
32
32 Cited Publications
製品番号: HY-19991
CAS 番号: 1675201-83-8
別名: PD-1/PD-L1 inhibitor 1
Target:  

PD-1/PD-L1 Apoptosis

研究分野:  

Inflammation/Immunology Cancer

BMS-1 is an inhibitor of the PD-1/PD-L1 protein/protein interaction (IC50 between 6 and 100 nM) .
loading...
    loading...
27
27 Cited Publications
製品番号: HY-P99144

Target:  

PD-1/PD-L1

研究分野:  

Inflammation/Immunology

Anti-Mouse PD-1 Antibody (RMP1-14) is an anti-mouse PD-1 IgG2a antibody. Anti-Mouse PD-1 Antibody (RMP1-14) can be used for the study of colon carcinoma .
loading...
    loading...
26
26 Cited Publications
製品番号: HY-19745
CAS 番号: 1675203-84-5
Target:  

PD-1/PD-L1 Apoptosis

研究分野:  

Cancer

BMS-202 is a potent and nonpeptidic PD-1/PD-L1 complex inhibitor with an IC50 of 18 nM and a KD of 8 μM. BMS-202 binds to PD-L1 and blocks human PD-1/PD-L1 interaction. BMS-202 has antitumor activity .
loading...
    loading...
26
26 Cited Publications
製品番号: HY-19745B
CAS 番号: 2089334-95-0
Target:  

PD-1/PD-L1 Apoptosis

研究分野:  

Cancer

BMS-202 hydrochloride is a potent and nonpeptidic PD-1/PD-L1 complex inhibitor with an IC50 of 18 nM and a KD of 8 μM. BMS-202 hydrochloride binds to PD-L1 and blocks human PD-1/PD-L1 interaction. BMS-202 hydrochloride has antitumor activity .
loading...
    loading...
24
24 Cited Publications
製品番号: HY-P9903
CAS 番号: 946414-94-4
別名: BMS-936558; ONO-4538; MDX-1106

Target:  

PD-1/PD-L1

研究分野:  

Infection Cancer

Nivolumab is a programmed death receptor-1 (PD-1) blocking human IgG4 antibody to treat advanced (metastatic) non-small cell lung cancer.
loading...
    loading...
19
19 Cited Publications
製品番号: HY-P99145

Target:  

PD-1/PD-L1

研究分野:  

Cancer

Anti-Mouse PD-L1/B7-H1 Antibody (10F.9G2) is an anti-mouse PD-L1/B7-H1 IgG2b antibody inhibitor derived from host rat. Anti-Mouse PD-L1/B7-H1 Antibody (10F.9G2) blocks PD-1 signaling. Anti-Mouse PD-L1/B7-H1 Antibody (10F.9G2) can be used for the research of cancer, such as colon cancer .
loading...
    loading...
9
9 Cited Publications
製品番号: HY-13993
CAS 番号: 169274-78-6
純度:  99.55%
Target:  

iGluR

研究分野:  

Neurological Disease

Ro 25-6981 is a potent, selective and activity-dependent NR2B subunit specific NMDA receptor antagonist. Ro 25-6981 shows anticonvulsant and anti-parkinsonian activity. Ro 25-6981 has the potential for the research of parkinson's disease (PD) .
loading...
    loading...
9
9 Cited Publications
製品番号: HY-13993A
CAS 番号: 1312991-76-6
純度:  99.25%
Target:  

iGluR

研究分野:  

Neurological Disease

Ro 25-6981 Maleate is a potent, selective and activity-dependent NR2B subunit specific NMDA receptor antagonist. Ro 25-6981 Maleat shows anticonvulsant and anti-parkinsonian activity. Ro 25-6981 Maleate has the potential for the research of parkinson's disease (PD) .
loading...
    loading...
6
6 Cited Publications
製品番号: HY-102011
CAS 番号: 1818314-88-3
純度:  99.49%
Target:  

PD-1/PD-L1

研究分野:  

Inflammation/Immunology Cancer

BMS-1166 is a potent PD-1/PD-L1 immune checkpoint inhibitor. BMS-1166 induces dimerization of PD-L1 and blocks its interaction with PD-1, with an IC50 of 1.4 nM. BMS-1166 antagonizes the inhibitory effect of PD-1/PD-L1 immune checkpoint on T cell activation .
loading...
    loading...
6
6 Cited Publications
製品番号: HY-102011A
CAS 番号: 2113650-05-6
純度:  99.31%
Target:  

PD-1/PD-L1

研究分野:  

Inflammation/Immunology Cancer

BMS-1166 hydrochloride is a potent PD-1/PD-L1 immune checkpoint inhibitor. BMS-1166 hydrochloride induces dimerization of PD-L1 and blocks its interaction with PD-1, with an IC50 of 1.4 nM. BMS-1166 hydrochloride antagonizes the inhibitory effect of PD-1/PD-L1 immune checkpoint on T cell activation .
loading...
    loading...
6
6 Cited Publications
製品番号: HY-P9919
CAS 番号: 1428935-60-7
別名: MEDI 4736

Target:  

PD-1/PD-L1

研究分野:  

Cancer

Durvalumab (MEDI 4736) is an human anti-PD-L1 monoclonal antibody . Durvalumab (MEDI4736) completely blocks the binding of PD-L1 to both PD-1 and CD80, with IC50s of 0.1 and 0.04 nM, respectively .
loading...
    loading...
6
6 Cited Publications
製品番号: HY-P9919A
CAS 番号: 1428935-60-7
別名: MEDI 4736 (anti-PD-L1)

Target:  

PD-1/PD-L1

研究分野:  

Cancer

Durvalumab (anti-PD-L1)(MEDI 4736) is a human anti-PD-L1 protein monoclonal antibody. Durvalumab (anti-PD-L1) completely blocks PD-L1 binding to PD-1 and CD80, IC 50 are 0.1 and 0.04 nM respectively, has anti-tumor activity .
loading...
    loading...
6
6 Cited Publications
製品番号: HY-16961
CAS 番号: 1123837-84-2
別名: MGCD516; MG-516
Sitravatinib (MGCD516) is an orally bioavailable receptor tyrosine kinase (RTK) inhibitor with IC50s of 1.5 nM, 2 nM, 2 nM, 5 nM, 6 nM, 6 nM, 8 nM, 0.5 nM, 29 nM, 5 nM, and 9 nM for Axl, MER, VEGFR3, VEGFR2, VEGFR1, KIT, FLT3, DDR2, DDR1, TRKA, TRKB, respectively . Sitravatinib shows potent single-agent antitumor efficacy and enhances the activity of PD-1 blockade through promoting an antitumor immune microenvironment .
loading...
    loading...
5
5 Cited Publications
製品番号: HY-P990679

Target:  

阻害性抗体

研究分野:  

Inflammation/Immunology Cancer

Rat IgG2a kappa, Isotype Control is a monoclonal antibody derived from rats, representing the immunoglobulin G2a (IgG2a) subclass with a kappa light chain. Rat IgG2a kappa, Isotype Control exhibits high efficiency in inducing K cell mediated cytotoxicity. Rat IgG2a kappa, Isotype Control is utilized in research investigating the roles of different immunoglobulin subclasses in tumor immunology. Rat IgG2a kappa, an isotype control, can be used as an isotype control for Anti-Mouse PD-1 Antibody (RMP1-14) (HY-P99144), Anti-Mouse CD11a/LFA-1α Antibody (M17/4) (HY-P990801), and Anti-Mouse IL-2 Antibody (S4B6-1) (HY-P990796) .
loading...
    loading...
4
4 Cited Publications
製品番号: HY-P81169A
別名: Programmed cell death protein 1; CD279; CD279 antigen; hPD 1; hPD-1; hSLE1; PD 1; PD1; PDCD 1; PDCD1; PDCD1_HUMAN; Programmed cell death 1; Protein PD 1; Protein PD-1; SLEB2; Systemic lupus erythematosus susceptibility 2.

Host:  

Mouse

Application:  

WB, IHC-P, ICC/IF, FC

Reactivity:  

Human

loading...
    loading...
4
4 Cited Publications
製品番号: HY-P9971
CAS 番号: 1798286-48-2
別名: SHR-1210; INCSHR1210

Target:  

PD-1/PD-L1

研究分野:  

Cancer

Camrelizumab (SHR-1210) is a potent humanied high-affinity IgG4-κ monoclonal antibody (mAb) to PD-1. Camrelizumab binds PD-1 at a high affinity of 3 nM and inhibits the binding interaction of PD-1 and PD-L1 with an IC50 of 0.70 nM. Camrelizumab acts as anti-PD-1/PD-L1 agent and can be used for cancer research, including NSCLC, ESCC, Hodgkin lymphoma, and advanced HCC et,al .
loading...
    loading...
3
3 Cited Publications
製品番号: HY-P7395
純度:  ≥ 95%, as determined by reducing SDS-PAGE.
別名: rHuPD-1, Fc Chimera; PD1; CD279; PDCD1
Species:  
Source:  
CHO
loading...
    loading...